{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:50:44Z","timestamp":1772805044772,"version":"3.50.1"},"reference-count":35,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1517\/14740338.2.3.263","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T16:16:25Z","timestamp":1115223385000},"page":"263-267","source":"Crossref","is-referenced-by-count":8,"title":["Hepatotoxic profile of catecholOmethyltranferase inhibitors in Parkinson\u2019s disease"],"prefix":"10.1517","volume":"2","author":[{"given":"Reina","family":"Benabou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,3,3]]},"reference":[{"issue":"2","key":"CIT0002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8619(18)30212-3","volume":"10","author":"TANNER CM","year":"1992","journal-title":"Neural. Clin."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.2.179"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200016010-00005"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(02)00040-8"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb04732.x"},{"key":"CIT0010","first-page":"81","volume":"48","author":"KURTH MC","year":"1997","journal-title":"ST HILAIRE M et al.: Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Neurology"},{"issue":"3","key":"CIT0011","first-page":"665","volume":"49","author":"WATERS CH","year":"1997","journal-title":"The Tolcapone Stable Study Group. Neurology"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420511"},{"issue":"5","key":"CIT0013","first-page":"1309","volume":"51","author":"RINNE UK","year":"1998","journal-title":"Nomecomt Study Group. Neurology"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2001.00168.x"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2002.1o174.x"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199619030-00004"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198713030-00002"},{"key":"CIT0018","unstructured":"NO AUTHORS LISTED: Comtan (entacapone). Package insert. Orion! Novartis Pharmaceuticals, East Hanover, NJ (1999)."},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1038\/247364b0"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.5.913"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90028-5"},{"issue":"6","key":"CIT0022","first-page":"719","volume":"360","author":"RUSS H","year":"1999","journal-title":"Nauriyri Schnhedebergs Arch. Phannacol"},{"key":"CIT0023","first-page":"407","volume":"1","author":"BARTHOLINI G","year":"1975","journal-title":"Marmara Ther."},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/265080a0"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.7.957"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360104"},{"key":"CIT0032","first-page":"22","volume":"47","author":"OBESO JA","year":"2000","journal-title":"Ann. Neural."},{"key":"CIT0033","unstructured":"NO AUTHORS LISTED: Tasmar' (tolcapone tablets) prescribing information. Roche Laboratories, Nutley, NJ (1998)."},{"key":"CIT0035","first-page":"958","volume":"352","author":"ASSAL E SPAHR L, HADENGUE A, RUBBBICI-BRANDT L, BURKHARD PR","year":"1998","journal-title":"Lancet"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050477"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.2.263"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10342"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005549304404"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01431-3"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1007\/s007020170099"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02383-X"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1078\/0940-2993-00228"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-002-0748-x"},{"issue":"5","key":"CIT0047","first-page":"327","volume":"2","author":"ACUNA G","year":"2002","journal-title":"Phannacogerionhcs J."}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.2.3.263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T21:54:03Z","timestamp":1550440443000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.2.3.263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,3,3]]},"published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1517\/14740338.2.3.263"],"URL":"https:\/\/doi.org\/10.1517\/14740338.2.3.263","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}